₹382.1
▼ -6.21 -1.60%
17 Jul 2026
NSE Listed · Pharmaceuticals
Gufic BioSciences Ltd. (GUFICBIO)
Volume: 26,930Avg Vol 1W: 18,619Avg Vol 1M: 77,83752W Range:₹268₹448
Key Ratios
Checked just nowMarket Cap₹3,832 Cr
Current Price₹382.1
Previous Close₹388.31
High / Low (52w)₹448 / ₹268
Volume26,930
Avg Vol (1W)18,619
Avg Vol (1M)77,837
Stock P/E59.7
Book Value₹66.31
Dividend Yield3%
ROE9.66%
ROA478.33%
Revenue (TTM)—
Revenue Growth1.63%
Profit Margin6.8%
Total Debt₹130 Cr
Shares Outstanding10 Cr
Face Value₹1
EPS (TTM)₹6.4
P/B5.76
Debt / Equity0.59
50 DMA₹379.32
200 DMA₹320.13
Day change-1.60%
Price Chart
₹382.1▲ 7.03% · 1Y
2025-11-252026-07-17
20-day avg volume: 71K shares
Pros
- Pays a dividend yield of 3.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 60.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹203 Cr | ₹204 Cr | ₹208 Cr | ₹205 Cr | ₹224 Cr | ₹237 Cr | ₹231 Cr | ₹252 Cr |
| EBITDA | ₹33 Cr | ₹34 Cr | ₹31 Cr | ₹19 Cr | ₹27 Cr | ₹32 Cr | ₹26 Cr | ₹38 Cr |
| Net Profit | ₹21 Cr | ₹22 Cr | ₹19 Cr | ₹8 Cr | ₹13 Cr | ₹17 Cr | ₹12 Cr | ₹22 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹385 Cr | ₹491 Cr | ₹782 Cr | ₹693 Cr | ₹809 Cr | ₹823 Cr |
| EBITDA | ₹44 Cr | ₹71 Cr | ₹132 Cr | ₹115 Cr | ₹131 Cr | ₹119 Cr |
| Net Profit | ₹23 Cr | ₹44 Cr | ₹96 Cr | ₹80 Cr | ₹86 Cr | ₹70 Cr |
| EPS | 2.34 | 4.56 | 9.89 | 8.22 | 8.74 | 6.95 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹408 Cr | ₹392 Cr | ₹521 Cr | ₹861 Cr | ₹1,093 Cr | ₹1,169 Cr |
| Total Liabilities | ₹278 Cr | ₹219 Cr | ₹252 Cr | ₹513 Cr | ₹560 Cr | ₹568 Cr |
| Equity | ₹129 Cr | ₹173 Cr | ₹269 Cr | ₹348 Cr | ₹533 Cr | ₹601 Cr |
| Total Debt | ₹20 Cr | ₹35 Cr | ₹48 Cr | ₹191 Cr | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹97 Cr | ₹139 Cr | ₹1 Cr | ₹20 Cr | ₹145 Cr |
| Investing | ₹-7 Cr | ₹-95 Cr | ₹-191 Cr | ₹-102 Cr | ₹-71 Cr |
| Financing | ₹-79 Cr | ₹-6 Cr | ₹234 Cr | ₹82 Cr | ₹-37 Cr |
| Free Cash Flow | ₹97 Cr | ₹139 Cr | ₹1 Cr | ₹20 Cr | ₹145 Cr |
Shareholding
Promoter 72.5% Institutions 4.26% Public 23.24%
Efficiency & Working Capital
ROCE11.5%
Interest Coverage4.8
Dividend Payout—
Debtor Days140 d
Inventory Days97 d
Payable Days71 d
Cash Conversion Cycle166 d
Working Capital Days237 d
Shareholding Details
As of 2026-03-31
Promoter72.5%
FII0.4%
DII3.8%
Institutions4.3%
Public23.2%
Promoter Pledge0%
No. of Shareholders29,223
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Oct 2023 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% |
| FIIs | 0.7% | 0.7% | 0.5% | 0.1% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% |
| DIIs | 1.6% | 1.6% | 1.6% | 2.2% | 2.4% | 2.5% | 3% | 3.4% | 3.4% | 3.7% | 3.7% | 3.8% |
| Public | 25.2% | 25.2% | 25.4% | 25.2% | 24.9% | 24.7% | 24.2% | 23.8% | 23.8% | 23.5% | 23.3% | 23.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 36,524 | 36,524 | 34,424 | 34,695 | 32,250 | 32,825 | 33,299 | 31,844 | 31,876 | 31,420 | 30,362 | 29,223 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Jayesh Pannalal Choksi | Shareholding of Promoter and Promoter Group | 24.6% | 2.47 Cr |
| Zircon Teconica Private Limited | Shareholding of Promoter and Promoter Group | 20.5% | 2.05 Cr |
| Gufic Private Limited | Shareholding of Promoter and Promoter Group | 10.2% | 1.02 Cr |
| Vipula Jayesh Choksi | Shareholding of Promoter and Promoter Group | 10% | 1.00 Cr |
| Pranav Jayesh Choksi | Shareholding of Promoter and Promoter Group | 7.3% | 72,68,626 |
| Motilal Oswal Financial Services Limited | Public Shareholding | 3.3% | 33,33,000 |
| Icici Prudential Multicap Fund | Public Shareholding | 2.1% | 21,21,225 |
| Jagdish N Master | Public Shareholding | 1.5% | 14,54,750 |
| Jal Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tricon Enterprises Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Motif Hotels Llp | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fc Kingsmen Llp | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Gufic Chem Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Zire Realty Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pooja Pranav Choksi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Meira Pranav Choksi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shiv Pranav Choksi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rita Ashok Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kshama Vipul Choksi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Forum Ameet Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jayesh Pannalal Choksi (huf) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Uma Lalit Trivedi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dhan Pankaj Zaveri | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Deepika Milan Barot | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pankaj Ramniklal Pandya | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Jayesh Pannalal Choksi | 0 | 0% | 2026-03-31 |
| Vipula Jayesh Choksi | 0 | 0% | 2026-03-31 |
| Pranav Jayesh Choksi | 0 | 0% | 2026-03-31 |
| Pooja Pranav Choksi | 0 | 0% | 2026-03-31 |
| Meira Pranav Choksi | 0 | 0% | 2026-03-31 |
| Shiv Pranav Choksi | 0 | 0% | 2026-03-31 |
| Rita Ashok Shah | 0 | 0% | 2026-03-31 |
| Kshama Vipul Choksi | 0 | 0% | 2026-03-31 |
| Forum Ameet Shah | 0 | 0% | 2026-03-31 |
| Jayesh Pannalal Choksi (huf) | 0 | 0% | 2026-03-31 |
| Uma Lalit Trivedi | 0 | 0% | 2026-03-31 |
| Dhan Pankaj Zaveri | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Jayesh P Choksi | Chairman / Executive Director / M D / Promoter | 2025 |
| Pranav J Choksi | ED / WTD / CEO / Promoter | 2025 |
| Pankaj Gandhi | Whole-time Director | 2025 |
| Anusanjiv Aurora | Independent Non Exe. Director | 2025 |
| Kamal Kishore Seth | Independent Non Exe. Director | 2025 |
| Akshya Kumar Mahapatra | Independent Non Exe. Director | 2025 |
| Ami Naresh Shah | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharma | ₹285 Cr | 93.8% |
| Bulk Drugs | ₹19 Cr | 6.2% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹654 Cr | 79.8% |
| Africa | ₹24 Cr | 2.9% |
| Asia | ₹50 Cr | 6% |
| Europe | ₹62 Cr | 7.5% |
| North America | ₹10 Cr | 1.2% |
| Australia | ₹1 Cr | 0.1% |
| South America | ₹19 Cr | 2.4% |
| Other | ₹0 Cr | 0% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 11 | 10 | 10 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-22 | ₹0.1 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 2 | 7 | 10 |
| 2025 | 0 | 0 | 0 | 2 | 7 | 10 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
2 recent disclosure(s)
JAYESH CHOKSIDisposal · 18,000
JAYESH CHOKSIDisposal · 4,50,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market02/06/2022 · 4,68,000
Company Information
Incorporated1984
ChairmanJayesh P Choksi
AuditorMittal Agarwal & Company
Investor Email[email protected]; mgr_legal@guficbi
📍 Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search